Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
TherapeuticsMD, Inc. (TXMD) had Stock-Based Compensation of $0.07M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.89M |
|
$-0.62M |
|
-- |
|
$0.89M |
|
$2.85M |
|
$-1.96M |
|
$1.38M |
|
$-0.58M |
|
$-0.58M |
|
$-0.61M |
|
$-0.61M |
|
$-0.62M |
|
$-0.61M |
|
$-1.96M |
|
$-1.06M |
|
11.57M |
|
11.57M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$14.45M |
|
-- |
|
$23.21M |
|
$37.66M |
|
$4.79M |
|
-- |
|
$6.00M |
|
$10.78M |
|
$26.88M |
|
$23.11M |
|
$26.88M |
|
11.57M |
|
| Cash Flow Statement Financials | |
$2.45M |
|
-- |
|
-- |
|
$5.06M |
|
$7.48M |
|
$2.42M |
|
|
Stock-Based Compensation |
$0.07M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-219.71% |
|
-219.71% |
|
-- |
|
-64.95% |
|
-69.32% |
|
$2.45M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.25 |
|
355.26 |
|
-2.28% |
|
-2.65% |
|
-1.63% |
|
-2.28% |
|
$2.32 |
|
$0.21 |
|
$0.21 |
|